Tags : Nanopore Sequencer

M&A MedTech

Roche Acquires Stratos Genomics to Advance the Development of Nanopore

Shots: Roche has acquired Stratos Genomics to facilitate the development of its nanopore sequencer to provide the healthcare community and ultimately patients with faster and cheaper clinical diagnostic testing The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). The addition of the SBX chemistry is expected to provide the HCPs […]Read More